Product
mRNA-1769
1 clinical trial
2 indications
Indication
SmallpoxIndication
Molluscum contagiosumClinical trial
A Randomised, Placebo-Controlled, Dose-Ranging, Observer-Blind Phase 1/2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of mRNA-1769 in Healthy ParticipantsStatus: Recruiting, Estimated PCD: 2025-05-30